Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-30T15:06:32.219Z Has data issue: false hasContentIssue false
  • English
  • Français

[No title]

Published online by Cambridge University Press:  29 January 2018

Konrad Michel  and
Tamara Kolakowska
Konrad Michel
Affiliation:
University of Oxford, Department of Psychiatry, Littlemore Hospital, Oxford, OX4 4XN
Tamara Kolakowska
Affiliation:
University of Oxford, Department of Psychiatry, Littlemore Hospital, Oxford, OX4 4XN
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Article
Information
The British Journal of Psychiatry , Volume 138 , Issue 3 , March 1981 , pp. 217 - 221
Copyright
Copyright © Royal College of Psychiatrists, 1981 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Diamond, H. Tislow, R. Snyder, T. & Rickels, K. (1976) Peer review of prescribing patterns in a CMHC. American Journal of Psychiatry, 133, 697–699.Google Scholar
Hemminki, E. (1977) Polypharmacy among psychiatric patients. Acta Psychiatrica Scandinavica, 56, 347–356.CrossRefGoogle ScholarPubMed
Hollister, L. E. (1975) Polypharmacy in psychiatry: Is it necessary, good or bad? In Rational Psychopharmacotherapy and the Right to Treatment (ed. F. J. Ayd ). Ayd Medical Communications Ltd., pp 19–28.Google Scholar
Klett, C. J. & Caffey, E. (1972) Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Archives of General Psychiatry, 26, 374–379.CrossRefGoogle ScholarPubMed
Laska, E. Varga, E. Wanderling, J. Simpson, G. Logemann, G. W. & Shah, B. K. (1973) Patterns of psychotropic drug use for schizophrenia. Diseases of the Nervous System, 34, 294–305.Google ScholarPubMed
McClelland, H. A. Blessed, G. Bhate, S. Ali, N. & Clarke, P. A. (1974) The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients. British Journal of Psychiatry, 124, 151–159.Google Scholar
Orlov, P. Kasparian, G. DiMascio, A. & Cole, J. O. (1971) Withdrawal of antiparkinson drugs. Archives of General Psychiatry, 25, 410–412.Google Scholar
Perris, C. Dimitrijevic, P. Jacobsson, L. Paulsson, P. Rapp, W. & Froberg, H. (1979) Tardive dyskinesia in psychiatric patients treated with neuroleptics. British Journal of Psychiatry, 135, 509–514.CrossRefGoogle ScholarPubMed
Prien, R. F. Balter, M. B. & Caffey, E. M. (1978) Hospital surveys of prescribing practices with psychotherapeutic drugs. Archives of General Psychiatry, 35, 1271–1275.CrossRefGoogle ScholarPubMed
Schroeder, N. H. Caffey, E. M. & Lorei, T. W. (1977) Antipsychotic drug use: Physician prescribing practices in relation to current recommendations. Diseases of the Nervous System, 38, 114–116.Google Scholar
Sheppard, C. Collins, L. Fiorentino, D. Fracchia, J. & Merlis, S. (1969) Polypharmacy in psychiatric treatment: 1. Incidence at a state hospital. Current Therapeutic Research, 11, 765–774.Google Scholar
Tyrer, P. (1978) Drug treatment of psychiatric patients in general practice. British Medical Journal, ii, 1008–1010.Google Scholar
Winstead, D. K. Blackwell, B. Eilers, M. K. & Anderson, A. (1976) Psychotropic drug use in five city hospitals. Diseases of the Nervous System, 37, 504–509.Google Scholar
Yosselson-Superstine, S. Sternik, D. & Liebenzon, D. (1979) Prescribing patterns in psychiatric hospitals in Israel. Acta Psychiatrica Scandinavica, 58, 477–482.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.